The “2021 IOL Market Report” features new forecasts reflecting the impact of the COVID-19 pandemic, the market’s recovery, and the backlog of patients still awaiting treatment. The pandemic decreased IOL units by nearly 25 percent and revenue by almost 15 percent, leaving room for significant growth in 2021 as surgeons work to reduce the backlog of patients.
The report includes updated analysis of premium IOLs as new trends have developed. More effective nondiffractive PC-IOLs are expected to expand the market, and phakic IOLs are becoming the fastest growing IOL segment.
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.